Rhythm Pharmaceuticals (RYTM) Other Working Capital Changes (2016 - 2026)

Rhythm Pharmaceuticals (RYTM) has 11 years of Other Working Capital Changes data on file, last reported at $487000.0 in Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at $487000.0, up 137.87% year-over-year; the trailing twelve-month figure through Mar 2026 was $8.1 million (up 318.51% YoY), and the FY2025 annual result was $6.3 million, changed N/A from the prior year.
• Other Working Capital Changes slipped to $487000.0 in Q1 2026 per RYTM's latest filing, from $2.7 million in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $11.3 million in Q2 2025 and troughed at -$6.4 million in Q3 2025.
• A 5-year average of $215000.0 and a median of $143500.0 in 2024 frame the typical range for Other Working Capital Changes.
• On a YoY basis, Other Working Capital Changes climbed as much as 1395.58% in 2025 and fell as far as 6123.58% in 2025.
• A 5-year view of Other Working Capital Changes shows it stood at $2.3 million in 2022, then plunged by 218.2% to -$2.7 million in 2023, then jumped by 106.63% to $181000.0 in 2024, then jumped by 1395.58% to $2.7 million in 2025, then slumped by 82.01% to $487000.0 in 2026.
• Business Quant data shows RYTM's Other Working Capital Changes at $487000.0 in Q1 2026, $2.7 million in Q4 2025, and -$6.4 million in Q3 2025.